Bone Tumor Department 2
骨肿瘤二科 · Peking University People's Hospital, Beijing
Established in 2025, this department specializes in the comprehensive management of bone and soft tissue tumors. It offers surgical interventions, chemotherapy, targeted therapy, and immunotherapy for conditions such as osteosarcoma, Ewing sarcoma, chondrosarcoma, chordoma, and giant cell tumor of bone. The team performs limb-sparing surgeries, complex resections of spinal and pelvic tumors, and functional reconstruction using customized 3D-printed prostheses. Digital technologies, including intraoperative fluorescence navigation and surgical robots, support precise tumor removal. The department also manages bone metastases through minimally invasive techniques and leads numerous clinical trials for new sarcoma drugs. A multidisciplinary team provides full-course care from diagnosis to rehabilitation.
Conditions and treatments
- Surgical and medical treatment for bone and soft tissue tumors
- Limb-sparing and joint-preserving surgery for extremity tumors
- Complex resection of spinal, sacral, and pelvic tumors
- Functional reconstruction with customized 3D-printed prostheses
- Chemotherapy, targeted therapy, and immunotherapy for malignant tumors
- Minimally invasive treatment for bone metastases
Key facts
- The department was established in 2025.
- There are 103 open beds and over 60 staff members.
- The department has secured over 90 million yuan in research funding.
Rewritten in English from the department's own description on a public doctor-listing platform. Claims such as "leading" are the hospital's own.
| Specialty | Bone and Soft Tissue Oncology |
|---|---|
| Doctors listed | 12 |
| Chief physicians | — |
We are an independent coordination service, not part of this hospital. Names and titles change; the hospital's website is the final word. How we build this directory.
Need a specialist's opinion?
Send your records and question. We find a specialist in the right field who reviews your case and tells you what they recommend.
Contact us